Logo image of VLA.PA

VALNEVA SE (VLA.PA) Stock Fundamental Analysis

EPA:VLA - FR0004056851 - Common Stock

3.843 EUR
+0.07 (+1.83%)
Last: 8/28/2025, 5:29:53 PM
Fundamental Rating

3

Overall VLA gets a fundamental rating of 3 out of 10. We evaluated VLA against 73 industry peers in the Biotechnology industry. VLA may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, VLA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year VLA has reported negative net income.
In the past year VLA has reported a negative cash flow from operations.
In the past 5 years VLA always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: VLA reported negative operating cash flow in multiple years.
VLA.PA Yearly Net Income VS EBIT VS OCF VS FCFVLA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M

1.2 Ratios

With an excellent Return On Assets value of 7.48%, VLA belongs to the best of the industry, outperforming 84.93% of the companies in the same industry.
VLA's Return On Equity of 20.65% is amongst the best of the industry. VLA outperforms 86.30% of its industry peers.
Industry RankSector Rank
ROA 7.48%
ROE 20.65%
ROIC N/A
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
VLA.PA Yearly ROA, ROE, ROICVLA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

VLA has a better Profit Margin (15.08%) than 82.19% of its industry peers.
With a Gross Margin value of 41.01%, VLA perfoms like the industry average, outperforming 53.42% of the companies in the same industry.
VLA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 15.08%
GM 41.01%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
VLA.PA Yearly Profit, Operating, Gross MarginsVLA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 -60

More info and screens

3

2. Health

2.1 Basic Checks

VLA does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, VLA has more shares outstanding
VLA has more shares outstanding than it did 5 years ago.
The debt/assets ratio for VLA has been reduced compared to a year ago.
VLA.PA Yearly Shares OutstandingVLA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
VLA.PA Yearly Total Debt VS Total AssetsVLA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of 0.04, we must say that VLA is in the distress zone and has some risk of bankruptcy.
VLA has a Altman-Z score (0.04) which is in line with its industry peers.
A Debt/Equity ratio of 1.06 is on the high side and indicates that VLA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.06, VLA is in line with its industry, outperforming 42.47% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Altman-Z 0.04
ROIC/WACCN/A
WACC8.25%
VLA.PA Yearly LT Debt VS Equity VS FCFVLA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

2.3 Liquidity

A Current Ratio of 2.61 indicates that VLA has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.61, VLA is doing good in the industry, outperforming 61.64% of the companies in the same industry.
A Quick Ratio of 2.14 indicates that VLA has no problem at all paying its short term obligations.
With a Quick ratio value of 2.14, VLA perfoms like the industry average, outperforming 57.53% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.61
Quick Ratio 2.14
VLA.PA Yearly Current Assets VS Current LiabilitesVLA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

5

3. Growth

3.1 Past

VLA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -95.65%.
VLA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.32%.
VLA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.09% yearly.
EPS 1Y (TTM)-95.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.25%
Revenue 1Y (TTM)10.32%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%26.98%

3.2 Future

The Earnings Per Share is expected to grow by 111.41% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 24.84% on average over the next years. This is a very strong growth
EPS Next Y-609.41%
EPS Next 2Y-99.8%
EPS Next 3Y111.41%
EPS Next 5YN/A
Revenue Next Year4.03%
Revenue Next 2Y13.55%
Revenue Next 3Y26.11%
Revenue Next 5Y24.84%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
VLA.PA Yearly Revenue VS EstimatesVLA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
VLA.PA Yearly EPS VS EstimatesVLA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

VLA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year VLA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VLA.PA Price Earnings VS Forward Price EarningsVLA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VLA.PA Per share dataVLA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

VLA's earnings are expected to grow with 111.41% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-99.8%
EPS Next 3Y111.41%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for VLA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VALNEVA SE

EPA:VLA (8/28/2025, 5:29:53 PM)

3.843

+0.07 (+1.83%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)08-12 2025-08-12/bmo
Earnings (Next)11-20 2025-11-20
Inst Owners23.31%
Inst Owner ChangeN/A
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap326.78M
Analysts83.33
Price Target7.64 (98.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-31.52%
Min EPS beat(2)-115.24%
Max EPS beat(2)52.2%
EPS beat(4)2
Avg EPS beat(4)-8.58%
Min EPS beat(4)-115.24%
Max EPS beat(4)72.74%
EPS beat(8)4
Avg EPS beat(8)-10.16%
EPS beat(12)5
Avg EPS beat(12)-55.58%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.5%
Min Revenue beat(2)-4.78%
Max Revenue beat(2)1.77%
Revenue beat(4)1
Avg Revenue beat(4)-7.74%
Min Revenue beat(4)-14.39%
Max Revenue beat(4)1.77%
Revenue beat(8)4
Avg Revenue beat(8)-2.47%
Revenue beat(12)6
Avg Revenue beat(12)43.18%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.58%
PT rev (3m)2.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-1.73%
EPS NY rev (3m)-1.73%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-2.69%
Revenue NY rev (3m)-2.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.32
P/FCF N/A
P/OCF N/A
P/B 1.8
P/tB 2.09
EV/EBITDA N/A
EPS(TTM)-0.45
EYN/A
EPS(NY)-0.28
Fwd EYN/A
FCF(TTM)-0.98
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS2.92
BVpS2.13
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 7.48%
ROE 20.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 15.08%
GM 41.01%
FCFM N/A
ROA(3y)-15.85%
ROA(5y)-14.17%
ROE(3y)-50.34%
ROE(5y)-55.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.2%
GM growth 5Y-7.06%
F-Score5
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 1.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 83.96%
Cap/Sales 6.63%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.61
Quick Ratio 2.14
Altman-Z 0.04
F-Score5
WACC8.25%
ROIC/WACCN/A
Cap/Depr(3y)101.58%
Cap/Depr(5y)231.17%
Cap/Sales(3y)9.04%
Cap/Sales(5y)14.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-95.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.25%
EPS Next Y-609.41%
EPS Next 2Y-99.8%
EPS Next 3Y111.41%
EPS Next 5YN/A
Revenue 1Y (TTM)10.32%
Revenue growth 3Y-21.31%
Revenue growth 5Y6.09%
Sales Q2Q%26.98%
Revenue Next Year4.03%
Revenue Next 2Y13.55%
Revenue Next 3Y26.11%
Revenue Next 5Y24.84%
EBIT growth 1Y82.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-262.99%
EBIT Next 3Y35.74%
EBIT Next 5Y30.38%
FCF growth 1Y61.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y66.85%
OCF growth 3YN/A
OCF growth 5YN/A